Roche Holding AG

Type: Company
Name: Roche Holding AG (Roche Holding Ltd)
Nationality: Switzerland
Web Address: http://www.roche.com/
Fact Sheet: Fact Sheet for Roche Holding AG
First reported Aug 26 2014 - Updated 5 hours ago - 15 reports

Roche To Acquire InterMune, Promising IPF Drug

By Roche announced that it is acquiring Brisbane-based biotech firm InterMune for $8.3 billion.Under the terms of the agreement, Roche will acquire InterMune at $74 per share on a fully diluted basis. Roche will submit a tender offer no later than August ... [Published Pharmaceutical Online - 5 hours ago]
First reported Aug 26 2014 - Updated 9 hours ago - 2 reports

Swiss Minister Postpones Russia Visit Over Ukraine Crisis

Wikicommons Swiss Economy Minister Johann Schneider-Ammann.A four-day visit to Russia in October by Switzerland's economy minister and high-profile Swiss business representatives has been postponed until next year due to the crisis in Ukraine, a government ... [Published Moscow Times - 9 hours ago]
First reported 17 hours ago - Updated 15 hours ago - 2 reports

Stock Investors Bid Up Shares of Roche Holding, Up 1.2%

One of today's notable stocks on the rise is Roche Holding (NASDAQ:RHHBY), up 1.2% to $36.76. The Dow is up 0.4% to 17,151 and the S&P is currently up 0.3% to 2, ... [Published Individual.com - 17 hours ago]
First reported Aug 25 2014 - Updated 19 hours ago - 3 reports

INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of InterMune, Inc. and Its Board of Directors In Connection With the Sale of the Company to Roche Holding AG -- ITMN

NEW YORK, Aug. 26, 2014 /PRNewswire/ -- Levi & Korsinsky is investigating the Board of Directors of InterMune, Inc. ("InterMune" or the "Company") (NASDAQ: ITMN)  for possible breaches of fiduciary duty and other violations of state law in connection ... [Published PR Newswire: Financial Services - 19 hours ago]
First reported Aug 25 2014 - Updated 21 hours ago - 4 reports

Spring Bioscience launches PD-L1 (SP142) rabbit monoclonal immunohistochemistry antibody1

Researchers develop new integrated approach to pinpoint genetic "drivers" of cancerResearchers find more selective therapies for cancerLeading European IT company invests $3 million in LogicNetsLandauer announces quarterly cash dividend of $0.55 per share ... [Published News-Medical.Net - Aug 25 2014]
First reported Aug 25 2014 - Updated Aug 26 2014 - 11 reports

Roche Acquires InterMune for US$8.3bn

The acquisition of InterMune, a Brisbane, California based biotechnology company focused on the research, development and commercialisation of innovative therapies in pulmonology and fibrotic diseases, will allow Roche to broaden and strengthen its r ... [Published BioPortfolio - Aug 26 2014]
First reported Aug 25 2014 - Updated Aug 26 2014 - 9 reports

S&P 500 index briefly crosses 2,000 for first time

U.S. stocks rose yesterday, briefly sending the Standard & Poor’s 500 Index above 2,000 for the first time ever, as corporate deal-making and prospects for economic stimulus in Europe bolstered confidence in the bull market.The S&P 500 rallied
0.5 percent ... [Published Boston Herald - Aug 26 2014]
First reported Aug 25 2014 - Updated Aug 26 2014 - 24 reports

Cravath, Davis Polk Lead on Latest Big Drug Buy

Roche Holding announced Monday its $8.3 billion acquisition of InterMune , a suburban San Francisco-based company lung disease drug developer, marking the latest in a series of deals by the Swiss drug giant.The proposed purchase of InterMune is Roche’s ... [Published American Lawyer.com - Aug 26 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 3 reports

S&P 500 tops 2,000 for first time in broad rally

NEW YORK: The S&P 500 stock index rose to an intraday record on Monday, topping 2,000 for the first time in a broad rally led by financial and biotechnology stocks.Major indexes opened higher, with the benchmark index hitting a record early in the session, ... [Published Economic Times - Aug 25 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 65 reports

Roche inks US$8.3b deal for InterMune

–NEW YORK: Roche Holding AG has agreed to buy United States biotech company InterMune Inc for US$8.3 billion (RM26.27 billion) in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector.The Swiss drugmaker said on Sunday ... [Published Yahoo! Malaysia - Aug 25 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 3 reports

Wall Street to watch for new home sales data

U.S. stock-index futures followed European shares higher on Monday, as traders digested comments by Federal Reserve Chair Janet Yellen and Mario Draghi, president of the European Central Bank (ECB).Speaking at the Jackson Hole symposium, Yellen appeased ... [Published CNBC - Aug 25 2014]
First reported Aug 25 2014 - Updated Aug 25 2014 - 2 reports

UPDATE: Roche climbs on deal; banks higher: Europe's stock moves

By Barbara Kollmeyer, MarketWatchMADRID (MarketWatch) -- Here are companies whose shares have made notable moves in European trade on Monday: Gainers: Heavyweight Roche Holding AG (RHHBY) rose 0.6% after announcing Sunday it will pay $8.3 ... [Published Morningstar.com - Aug 25 2014]

Quotes

Firelli Alonso-Caplen, outsourcing manager for 10 years, first at Wyeth and then Pfizer, says "The key really is the initial selection process for the CDMO" in a recent conversation regarding our panel at Outsourced Pharma West Conference, in San Francisco...
Original Article: NEXT ARTICLE More From BioPortfolio on "With An Iffy Non-Oncology Pipeline, Roche Pays Up For InterMune"
5. "In total, we have a broad pipeline of 14 antibodies in clinical development, six of which are partnered with Sanofi ( NYSE: SNY"
NEXT ARTICLE More From BioPortfolio on "Combo Craze: For PD-1s, Research Alliances Are The Order Of The Day"

More Content

All (1987) | News (1661) | Reports (1) | Blogs (268) | Audio/Video (1) | Fact Sheets (27) | Press Releases (23)
sort by: Date | Relevance
08.26.14 -- Learn Pfizer's Guiding Principles F... [Published Pharmaceutical Online - 5 hours ago]
Roche To Acquire InterMune, Promising IPF Drug [Published Pharmaceutical Online - 5 hours ago]
With An Iffy Non-Oncology Pipeline, Roche Pays ... [Published BioPortfolio - 6 hours ago]
Western drugmakers try to shop their way out of... [Published Nikkei Asian Review - 6 hours ago]
In 2013, Chinese in vitro diagnostics market to... [Published Live-PR.com - 7 hours ago]
Diagnostics are rising up the pharma value chain [Published PMLive - 7 hours ago]
7 Things Regeneron Pharmaceuticals Inc.'s Manag... [Published Motley Fool Discussion Boards - 8 hours ago]
Swiss Minister Postpones Russia Visit Over Ukra... [Published Moscow Times - 9 hours ago]
EMD Millipore to supply Samsung's Yervoy plant ... [Published In-Pharmatechnologist - 9 hours ago]
Combo Craze For PD1s Research Alliances Are The... [Published BioPortfolio - 10 hours ago]
Benchmark Wall St share index closes above 2,00... [Published Yahoo! News Australia - 11 hours ago]
With An Iffy Non-Oncology Pipeline, Roche Pays ... [Published Seeking Alpha - 11 hours ago]
Combo Craze: For PD-1s, Research Alliances Are ... [Published Health News Daily - 11 hours ago]
INVESTOR ALERT – InterMune, Inc.: The Law Offic... [Published EON Business - 11 hours ago]
INVESTOR ALERT – InterMune, Inc.: The Law Offic... [Published Business Wire Professional Services News - 11 hours ago]
Roche Furthers Immunotherapy Program with SP142... [Published Zacks.com - 13 hours ago]
Roche creates M&A headlines with Intermune purc... [Published BioPortfolio - 14 hours ago]
Illumina partners big pharma for 'one gene test... [Published BioNews - 15 hours ago]
Glucose Test Strips: What's Next [Published Printed Electronics World - 15 hours ago]
Roche to acquire 100% stake in InterMune [Published Individual.com - 16 hours ago]
Cooley Guides Gilead Sciences to High Stakes Vi... [Published Cooley - 16 hours ago]
S&P tops 2000 but fears remain over end of bull... [Published TradingCharts.com - 16 hours ago]
Roche is beefing up its respiratory drug portfo... [Published BioPortfolio - 16 hours ago]
Stock Investors Bid Up Shares of Roche Holding,... [Published Individual.com - 17 hours ago]
Stock Investors Bid Up Shares of Roche H... [Published Financial News Network online - 17 hours ago]
Global Cytomegalovirus Retinitis Market 2014-20... [Published PR Newswire: Health - 19 hours ago]
Roche and InterMune in definitive merger agreement [Published Express Pharma - 19 hours ago]
INVESTOR ALERT: Levi & Korsinsky, LLP Announces... [Published PR Newswire: Financial Services - 19 hours ago]
Active Pharmaceutical Ingredients Global Market... [Published Individual.com - 19 hours ago]
Employers make the business case for benefits t... [Published BenefitNews.com - 19 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
INVESTOR ALERT – InterMune, Inc.: The Law Offic... [Published EON Business - 11 hours ago]
NEW YORK--(EON: Enhanced Online News)--The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of InterMune, Inc. (Nasdaq:ITMN) in connection with the sale of the Company ...
INVESTOR ALERT – InterMune, Inc.: The Law Offic... [Published Business Wire Professional Services News - 11 hours ago]
NEW YORK--(BUSINESS WIRE)--The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of InterMune, Inc. (Nasdaq:ITMN) in connection with the sale of the Company ...
Global Cytomegalovirus Retinitis Market 2014-20... [Published PR Newswire: Health - 19 hours ago]
DUBLIN, Aug. 26, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Cytomegalovirus Retinitis Market 2014-2018" report to their offering. Cytomegalovirus retinitis is a viral eye inflammation of the retina. The causative ...
INVESTOR ALERT: Levi & Korsinsky, LLP Announces... [Published PR Newswire: Financial Services - 19 hours ago]
NEW YORK, Aug. 26, 2014 /PRNewswire/ -- Levi & Korsinsky is investigating the Board of Directors of InterMune, Inc. ("InterMune" or the "Company") (NASDAQ: ITMN)  for possible breaches of fiduciary duty and other violations of state law in connection ...
INVESTOR ALERT: Faruqi & Faruqi, LLP Announces ... [Published PR Newswire: Financial Services - Aug 26 2014]
NEW YORK, Aug. 25, 2014 /PRNewswire/ -- Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Intermune, Inc. ("InterMune" or the "Company") ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
Roche to pay $1.7bn for Seragon [Published Reuters Video: Business - Jul 02 2014]
1

Press Releases

sort by: Date | Relevance
SHAREHOLDER ALERT: Pomerantz LLP Investigates C... [Published Financial Services - Aug 25 2014]
INVESTOR ALERT - InterMune, Inc.: The Law Offic... [Published Financial Services - Aug 25 2014]
Harwood Feffer LLP Announces Investigation of I... [Published Financial Services - Aug 25 2014]
Spring Bioscience launches highly sensitive PD-... [Published Financial Services - Aug 25 2014]
Shareholder Alert: Bronstein, Gewirtz & Grossma... [Published Financial Services - Aug 25 2014]
1 2 3 4 5
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.